CCP
LLY icon

Clarity Capital Partners’s Eli Lilly LLY Stock Holding History

Clarity Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-257
Closed -$212K – 123
2025
Q1 		$212K Sell
257
-1,987
-89% -$1.65M 0.09% 105
2024
Q4 		$1.73M Buy
2,244
+141
+7% +$117K 0.9% 29
2024
Q3 		$1.86M Buy
2,103
+1,795
+583% +$1.61M 1.1% 25
2024
Q2 		$279K Sell
308
-81
-21% -$64.8K 0.17% 93
2024
Q1 		$303K Buy
+389
New +$277K 0.2% 90

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clarity Capital Partners's LLY Position: Q2 2025 in Review

Clarity Capital Partners sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 257 shares — an estimated $212K sold.

Clarity Capital Partners first reported a position in LLY in Q1 2024 and held it in 5 quarters. The position peaked at $1.86M in Q3 2024. 3,908 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Clarity Capital Partners reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Clarity Capital Partners sold 257 Eli Lilly shares in Q2 2025, an estimated $212K.
  • Clarity Capital Partners first reported a position in Eli Lilly in Q1 2024 and held it in 5 quarters.
  • Clarity Capital Partners's Eli Lilly position peaked at $1.86M in Q3 2024.
  • 3,908 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Clarity Capital Partners's 13F filing for Q2 2025, filed 21 Jul 2025.